At Miraca we believe in healthy collaboration for healthier patients, and this tenet applies also to our technology partnerships. To serve our physician clients, Miraca Life Sciences has carefully selected and partnered with a number of specialized vendors.

We work closely with each partner to offer solutions that maximize the efficiency of your practice.

  • gMed — We offer gMedConnect to gastroenterology practices for a low monthly subscription fee.
  • ProVation — Through Miraca's partnership with ProVation, you can add the ProVation MD endoscopy report writing software to your practice at an affordable price.
  • Modernizing Medicine — For dermatologists who use the EMA EMR, we have significantly enhanced how our pathologists use diagnostic information.

The Miraca team proudly brings these outstanding technology companies to our physician clients to enhance the day-to-day business of running your practice.

Miraca Life Sciences is investing in where the market is going: converged, cloud-ready, fully-integrated technology solutions. We expand the diversity of our offerings and our ability to deliver relevant practice solutions through our strategic relationships with leading specialty-specific vendors. Find the program that fits your business.

Continuous electronic connection with patients and healthcare partners is the business model of the new millennium. Downtime is not an option. That's why Miraca Life Sciences is offering practice solutions designed specifically for this new electronic economy. Miraca is aggressively building unique specialty-specific expertise with every technology partnership and e-business solution that we offer in order to provide customized architectures and products that fit your practice.

Importantly, our consulting expertise and implementation experience deepens and broadens our solution portfolio and industry capabilities. Miraca’s broad spectrum of best-in-class service offerings aims to meet your every business need, whether simple or complex.

Contact Miraca Life Sciences to learn how Miraca can assist your practice
Call 1.866.588.3280 or email

Choose Miraca for Your Patients

Learn more about Miraca's Anatomic Pathology services

Learn More »

I have to tell you… what an excellent tech support team Miraca has. They are always available and ready to help me with any issues that Danbury Surgical Center has.
— Ellen Basson, RN
Danbury Surgical Center

Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.

Recent News

September 22, 2017

Avista Capital Partners to Acquire Miraca Life Sciences

IRVING, TX, NEW YORK, NY, and TOKYO, September 22, 2017 – Avista Capital Partners (“Avista”), a leading private equity firm, and Miraca Holdings Inc. (“MHD”) announced today that Avista has signed a definitive agreement to acquire Miraca Life Sciences (“MLS” or “the Company”), a wholly-owned subsidiary of Miraca Holdings Inc. Continue reading press release

Continue reading

April 18, 2017

Miraca Research News: Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

Pathologists at Miraca Life Sciences contributed significantly in the development of a new product from Philips, the IntelliSite Pathology Solution. As one of four clinical study sites, Miraca Life Sciences participated in “one of the largest studies ever conducted to directly compare the use of digital pathology to optical microscopes.” At Miraca, participation in the Philips study was a project of Miraca […]

Continue reading

April 11, 2017

Ten Research Projects from Miraca Life Sciences Accepted for DDW Conference

IRVING, Texas, April 12, 2017 — Ten research projects from the GI pathologists at Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, have been accepted for presentation at the Digestive Disease Week® conference (DDW), which will be held May 6–9 in Chicago. DDW is the world’s largest gathering of physicians, researchers and industry in the fields of gastroenterology, […]

Continue reading

March 27, 2017

Simponi® is Sixth Drug in InformTx™ Therapeutic Drug Monitoring Service from Miraca Life Sciences

IRVING, Texas, March 28, 2017 — Miraca Life Sciences, the largest U.S. independent anatomic pathology laboratory, continues to expand its InformTx™ therapeutic drug monitoring (TDM) capabilities, now testing for Simponi (golimumab) as well as patient-developed antibodies to Simponi. This is the first TDM assay available in the United States for Simponi. With this addition, Miraca Life Sciences now performs TDM […]

Continue reading

November 30, 2016

Stelara® Now Available for Therapeutic Drug Monitoring from Miraca Life Sciences

IRVING, Texas, December 1, 2016 — Miraca Life Sciences, the largest U.S. independent anatomic pathology lab, has expanded its InformTx™ therapeutic drug monitoring service for drugs that treat inflammatory bowel disease (IBD) with the addition of Stelara (ustekinumab).

Miraca Life Sciences continues to perform therapeutic drug monitoring (TDM) for Remicade® (infliximab), Humira® (adalimumab), Cimzia® (Certolizumab pegol) and Entyvio® (vedolizumab). Since […]

Continue reading